Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human monoclonal antibody targeting TNFR2 for cancer immunotherapy

Human monoclonal antibody targeting TNFR2 for cancer immunotherapy

US Patent 11389480 · Granted Jul 19, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) a2025
Method for generating a reference trajectory within a lane, method for operating2025
Compositions and methods for treating cancer with anti-BCMA immunotherapy2025
Compositions and methods for treating cancer with anti-CD38 immunotherapy2025
Compositions and methods for treating cancer with anti-CD38 immunotherapy2025
ADAM17 binding molecules and uses thereof2025
ADAM17 binding molecules and uses thereof2025
Nucleotide derivatives and methods of use thereof2025
Compounds and methods for the targeted degradation of androgen receptor2025
Compounds and methods for the enhanced degradation of targeted proteins2025
Nucleotide analogues and use thereof for nucleic acid sequencing and analysis pr2025
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses ther2024